Concepedia

Ludwig Cooymans

LC

Statistics

Publications

3

Citations

69

H-Index

3

Active since

2019

Affiliations

Janssen (Belgium)(Current)

Ludwig Cooymans is an author at Janssen (Belgium) specializing in antiviral therapy, pharmacy, and antiviral pharmacology.

Publications per year

2019–2024

3

Publications

3

Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1<i>H</i>-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus

Sandrine Vendeville, Abdellah Tahri, Lili Hu et al. · Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +16

Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region

David C. McGowan, Wendy Balemans, Werner Embrechts et al. · Journal of Medicinal Chemistry · 2019 · 28 citations · Full text

, , +17

Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors

Sandrine Grosse, Ludwig Cooymans, Werner Embrechts et al. · Journal of Medicinal Chemistry · 2024 · 10 citations

, , +17

1–3 of 3